GH News and Press, Guardant Health Inc. From 02/21/24

2024-02-21 17:20:45 ET More on Guardant Health Guardant Health: Vast Market Opportunity, Challenging Valuation Guardant Health forecasts upbeat Q4, 2023 revenue guidance It's JPM time! Which medtechs are expected to issue updates this week? Seeking Alpha ...

2024-02-20 16:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Thursday, February 22, 2024. Company management will webcast a corresponding conference call beginning at 1:30...

2024-01-28 09:25:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips I’m bullish on the long-term trajectory of personalized medicine stocks. These companies specialize in tailoring a holistic approach to healthcare, with medical treatments tailored to th...

2024-01-20 10:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. With bond yields falli...

2024-01-19 12:42:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Easing financial condi...

2024-01-19 05:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-17 21:22:40 ET Summary Shares of Oxford Nanopore declined by 33% after slower than expected growth in the second half of 2023. Positive outlook on the company, but profitability not expected until 2026. Challenging market with slow adoption of new technology, but new p...

COSMOS study shows Guardant Reveal™ blood test highly predictive for disease recurrence in patients with early-stage colon cancer without need for tissue specimen Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present interim data from the COSMOS s...

2024-01-08 14:48:03 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips 2023 was dominated by the Magnificent Seven stocks, which has left investors wondering how much higher mega-cap stocks can go. Investors worry that growth is nearing a peak or perhaps reversing...